SCHEMBL14280883

SCHEMBL14280883

COc1ccc(C(=O)/C=C/c2cc(Br)ccc2N2CCN(C)CC2)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPS1 P31327 6/20 0.48
HPGD P15428 4/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
LMNA P02545 4/20 0.47
ALDH1A1 P00352 4/20 0.47
GAA P10253 2/20 0.47
ALOX12 P18054 1/20 0.47
APP P05067 1/20 0.44
MAPT P10636 5/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
POLB P06746 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MCL1 Q07820 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
PAX8 Q06710 1/20 0.42
BLM P54132 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3687512 1.00 CPS1 (0.48) CPS1HPGDMEN1KMT2ALMNA
SCHEMBL3687434 0.96 CPS1 (0.45) CPS1HPGDMEN1KMT2ALMNA
SCHEMBL3687509 0.89 ALDH1A1 (0.47) HPGDMEN1KMT2ALMNAALDH1A1
SCHEMBL3693000 0.89 ALDH1A1 (0.47) HPGDMEN1KMT2ALMNAALDH1A1
SCHEMBL3688857 0.88 CPS1 (0.48) CPS1HPGDMEN1KMT2ALMNA
SCHEMBL3690191 0.87 BACE1 (0.45) CPS1HPGDMEN1KMT2ALMNA
SCHEMBL3690195 0.87 BACE1 (0.45) CPS1HPGDMEN1KMT2ALMNA
SCHEMBL3686775 0.87 CPS1 (0.47) CPS1HPGDMEN1KMT2ALMNA
SCHEMBL3686269 0.86 CPS1 (0.46) CPS1HPGDMEN1KMT2ALMNA
SCHEMBL3687432 0.86 ALDH1A1 (0.44) CPS1HPGDMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080027075-A1 Quaternary Amino-Function Chalcones LICA PHARMACEUTICALS A/S (DK) 2008-01-31 US disclosed
US-20080027075-A1 Quaternary Amino-Function Chalcones LICA PHARMACEUTICALS A/S (DK) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027075-A1 Quaternary Amino-Function Chalcones NR2E1, BET1, NR0B1 CPS1 2459/4885HPGD 4406/4885MEN1 3513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.